The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/20918
StudyName: Serious Adverse Event Report in Clinical Trials PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062
Date of export from the portal: 02.07.2020
Date of Upload / last change: 27.03.2017
License: Creative Commons BY 4.0

----

Description: 
The purpose of the trial is to determine if extended-release dipyridamole + aspirin [Aggrenox, Asasa ntin] is superior to clopidogrel [Plavix], and if telmisartan [Micardis, Gliosartan, Kinzal, Kinzalm ono, Predxal, Pritor, Samertan, Telmisartan] is superior to placebo, in the presence of background antihypertensive therapy, in prevention of a second stroke in patients who have recently suffered a stroke and therefore are at high risk of suffering another one. 

For Serious and Significant Adverse Events, this form is to be completed by the investigator and forwarded immediately to the sponsor (preferably additionally by Fax).

Study Source & Descriptions: https://clinicaltrials.gov/ct2/show/NCT00153062?term=NCT00153062&rank=1
